Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
340B HEALTH RESPONDS TO SENATE REQUEST FOR INFORMATION ON 340B
-
HOSPITAL LEADER KAREN L. BOWLING ASSUMES CHAIR OF 340B HEALTH BOARD OF DIRECTORS
-
DRUGMAKERS THREATENING $8.4 BILLION OF 340B HOSPITAL FUNDING THROUGH RESTRICTIONS
-
STATEMENT ON CMS PROPOSED REMEDY FOR UNLAWFUL 340B MEDICARE PAYMENT CUTS
-
ASTELLAS RESTRICTING 340B DISCOUNTS FOR COSTLY PROSTATE CANCER TREATMENT THROUGH COMMUNITY-BASED PHARMACIES
-
STATEMENT ON SENATE REQUEST FOR INFORMATION ON SAFEGUARDING AND STRENGTHENING 340B
-
STATEMENT ON TEVA RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES
-
STATEMENT ON 22ND DRUG COMPANY REFUSING TO OFFER 340B DRUG PRICING; NOVO NORDISK FURTHER RESTRICTS 340B CONTRACT PHARMACY PRICING
-
STATEMENT ON COMMITTEE PASSAGE OF HARMFUL HOUSE 340B LEGISLATION
-
JOINT STATEMENT FROM NATIONAL HOSPITAL AND PHARMACIST ASSOCIATIONS ON HARMFUL HOUSE 340B LEGISLATION
-
STATEMENT ON HOUSE SUBCOMMITTEE APPROVAL OF 340B REPORTING MANDATE
-
AHA, 340B HEALTH, ARKANSAS HOSPITAL ASSOCIATION URGE FEDERAL APPEALS COURT TO UPHOLD STATE LAW PROTECTING 340B COMMUNITY PHARMACIES